Table 1 Demographics of the patients at the first qualifying scan for analysis.
Baseline ejection fraction group | 56%-62% | 63%-70% |
|---|---|---|
N | 109 | 216 |
Age | 26.6 (8.6) | 26.6 (8.7) |
Sex | Â | Â |
   Male N (%) | 59 (54.1) | 110 (53.4) |
   Female N (%) | 50 (45.9) | 96 (46.6) |
Ethnicity | Â | Â |
   Indian N (%) | 31 (28.4) | 56 (27.2) |
   Greek N (%) | 18 (16.5) | 31 (15.1) |
   Cypriot N (%) | 17 (15.6) | 30 (14.6) |
   Pakistani/Bangladeshi N (%) | 14 (12.8) | 32 (14.8) |
   Turkish/Arabic N (%) | 12 (11.0) | 18 (8.3) |
   Italian/Romanian N (%) | 6 (5.5) | 12 (5.6) |
   Chinese/Malay N (%) | 5 (4.6) | 4 (2.0) |
   Unknown N (%) | 7 (6.4) | 20 (9.3) |
Ferritin [ug/L] | 2140 (1600) | 2065 (1636) |
Cardiac T2* [ms] | 19.7 (13.3) | 23.2 (13.8) |
Liver T2* [ms] | 4.5 (4.3) | 5.1 (4.6) |
LVEDV [mL] | 132.1 (33.5) | 128.3 (38.4) |
LVESV [mL] | 49.3 (19.9) | 43.8 (19.0) |
LVEF [%] | 59.7 (1.8) | 66.7 (2.3) |
Treatment | Â | Â |
   DFO N (%) | 72 (66.1) | 109 (52.9) |
   DFP N (%) | 10 (9.2) | 35 (17.0) |
   DFX N (%) | 3 (2.75) | 6 (2.9) |
   DFO + DFP N (%) | 22 (20.2) | 50 (24.3) |
   DFO + DFX N (%) | 1 (0.9) | 0 (0) |
   None N (%) | 1 (0.9) | 6 (2.9) |